ELISA News and Research

RSS
New Stad Center for Pediatric Pain, Palliative & Integrative Medicine launched with a $3 million gift

New Stad Center for Pediatric Pain, Palliative & Integrative Medicine launched with a $3 million gift

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

Study assesses the safety of breastfeeding during maternal SARS-CoV-2 infection

Study assesses the safety of breastfeeding during maternal SARS-CoV-2 infection

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

Development of a rapid, inexpensive and highly accurate diagnostic method to fight African Swine Fever

Development of a rapid, inexpensive and highly accurate diagnostic method to fight African Swine Fever

Study measures viral antigen and inflammatory biomarkers in CSF of COVID-19 patients in relation to neurologic symptoms and disease severity

Study measures viral antigen and inflammatory biomarkers in CSF of COVID-19 patients in relation to neurologic symptoms and disease severity

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

Anti-SARS-CoV-2 antibodies from breast milk persist in infants’ digestive tract

Anti-SARS-CoV-2 antibodies from breast milk persist in infants’ digestive tract

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

Important methodology for targeting conserved epitopes of SARS-CoV-2 and an immune-focused approach in pan-sarbeco and universal CoV vaccine design

Important methodology for targeting conserved epitopes of SARS-CoV-2 and an immune-focused approach in pan-sarbeco and universal CoV vaccine design

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Study investigates the detection of antibodies against SARS-CoV-2 in urine

Study investigates the detection of antibodies against SARS-CoV-2 in urine

Immunity conferred by COVID-19 vaccines in solid organ transplant recipients

Immunity conferred by COVID-19 vaccines in solid organ transplant recipients

Recombinant protein vaccine stands up to SARS-CoV-2 variants

Recombinant protein vaccine stands up to SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.